HHS OIG Issues Guidance on Anti-Kickback Statute Implications for Direct-to-Consumer Drug Sales Ahead of TrumpRx Launch

McGuireWoods·Feb 5

This story is reported by McGuireWoods. Read what other outlets are saying below, then open the original report for full details.